Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – Medix 21 Australia Pty Ltd - 196618

Overview

The Therapeutic Goods Act 1989, enacted by the Australian Parliament, governs the regulation of therapeutic goods in Australia, including medical devices. The Act aims to protect public health by ensuring that therapeutic goods are of acceptable quality and safe for use. The legislation provides a framework for the registration, evaluation, and monitoring of therapeutic goods, including medical devices. In 2013, the Government introduced a Gazette, C2013G00652, to address the issue of non-compliance with the definition of a medical device as stipulated under section 41BD(a) of the Act. This Gazette highlights the cancellation of an entry for a kind of medical device from the Australian Register of Therapeutic Goods, as it was found that the products did not meet the required definition of a medical device at the time of the application, and were therefore considered excluded goods under subsection 7(4)(b) of the Therapeutic Goods (Excluded Goods) Order No 1 of 2011. The policy objective of this action is to maintain the integrity of the Australian Register of Therapeutic Goods and ensure that only products meeting the necessary safety and quality standards are available for use in Australia.

Scope and Application

The Therapeutic Goods Act 1989, under section 41GP, governs the publication of the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods. This Act applies to any entity that manufactures, supplies, or advertises therapeutic goods within Australia, including companies, individuals, and entities involved in the import, export, or distribution of such goods. The Act has a national reach, extending across all states and territories within the Commonwealth of Australia. The Act’s application is not limited to specific thresholds or exemptions, except as outlined in subordinate instruments such as the Therapeutic Goods (Excluded Goods) Order No 1 of 2011, which may provide specific exclusions. In this particular instance, the cancellation pertains to a kind of medical device, specifically a chair, toilet, with ARTG number 196618, manufactured by Rifton Equipment (USA) and sponsored by Medix 21 Australia Pty Ltd. The cancellation was effective from 31 May 2013, following a determination that the products did not meet the definition of a medical device as stipulated under section 41BD(a) of the Act, and were thus excluded goods under the Therapeutic Goods (Excluded Goods) Order.

Key Provisions

The main operative sections of this legislation are sections 41GN(1)(f) and 41BD(a) of the Therapeutic Goods Act 1989 (the Act). Section 41GN(1)(f) allows for the cancellation of an entry from the Australian Register of Therapeutic Goods (ARTG) if the product does not meet the definition of a medical device as specified under section 41BD(a) of the Act. In this case, the entry for a toilet chair under ARTG number 196618 has been cancelled because the product does not meet the definition of a medical device and is classified as an excluded good under the Therapeutic Goods (Excluded Goods) Order No 1 of 2011. The obligations imposed by the Act on the parties involved include ensuring that the products supplied under the ARTG inclusion meet the definition of a medical device as per section 41BD(a) of the Act. The sponsor, Medix 21 Australia Pty Ltd, and the manufacturer, Rifton Equipment (USA), are required to ensure that their products are correctly classified and meet the necessary standards for inclusion in the ARTG. Failure to comply with these requirements can result in the cancellation of the product’s entry, as evidenced by the cancellation of the toilet chair entry. Breach of the Act’s provisions, particularly in relation to the misclassification of products, can lead to significant consequences. The cancellation of the ARTG entry for the toilet chair is a direct result of non-compliance with the definition of a medical device. The legislative text does not specify the exact penalties for such breaches, but it is clear that non-compliance can lead to the removal of a product from the ARTG, potentially impacting market access and consumer safety. Additionally, repeated or egregious breaches could potentially result in further regulatory actions, including fines or legal proceedings against the entities involved.